Document Detail


Gestational changes in endothelium-dependent vasorelaxation in human umbilical artery.
MedLine Citation:
PMID:  8296828     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: We intended to clarify whether (1) the amount of endothelium-derived vasorelaxing factor or nitric oxide released by histamine is sufficient to cause relaxation in human umbilical artery at different stages of gestation and (2) the functional role of endothelium-derived relaxing factor changes with the progress of gestation. STUDY DESIGN: By means of a bioassay cascade technique with very thin muscle strips, which allows rapid diffusional access of applied drugs (of the order of a few seconds), contractile properties were examined. RESULTS: At 18 to 22 weeks of gestation histamine produced only a minor contraction, but as gestation progressed the contractile responses increased. L-NG-nitro-arginine greatly enhanced the histamine-induced contractions. Histamine produced a concentration-dependent relaxation during the maintained contraction induced by 39 mmol/L K+ in tissues from 18 to 22 weeks or 30 to 32 weeks but not 38 to 41 weeks of gestation. Thus the concentration-relaxation relationship for histamine showed decreased sensitivity during gestation. The histamine-induced relaxation was enhanced by superoxide dismutase and completely blocked by L-NG-nitro-arginine or mepyramine (H1 antagonist). The concentration-relaxation relationship for the action of glycerol trinitrate relaxation decreased as gestation progressed. In a bioassay cascade an endothelium-intact umbilical artery from 18 to 22 or 38 to 41 weeks of gestation was used as a "donor" and L-NG-nitro-arginine-treated umbilical artery from 18 to 22 and 38 to 41 weeks as a "detector." In the presence of histamine the perfusate that had passed through a donor from 18 to 22 weeks (but not 38 to 41 weeks) attenuated the high K(+)-induced contraction in the detector only from 18 to 22 weeks. CONCLUSION: These results suggest that the amount of endothelium-derived relaxing factor and the sensitivity of smooth muscle to endothelium-derived relaxing factor decreased with the progress of gestation.
Authors:
H Izumi; R E Garfield; Y Makino; K Shirakawa; T Itoh
Related Documents :
11168318 - Comparisons of cutaneous blood flow reactivity to norepinephrine and sodium nitroprussi...
16614358 - Bimodal distribution of vasodilator responsiveness to adenosine due to difference in ni...
5564398 - The peripheral vascular response to severe exercise in untethered dogs before and after...
15475528 - Cyclooxygenase products sensitize muscle mechanoreceptors in healthy humans.
2407468 - Adaptations and limitations in the pulmonary system during exercise.
16636928 - Temporal changes in the inequality of early growth of cunninghamia lanceolata (lamb.) h...
Publication Detail:
Type:  In Vitro; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  American journal of obstetrics and gynecology     Volume:  170     ISSN:  0002-9378     ISO Abbreviation:  Am. J. Obstet. Gynecol.     Publication Date:  1994 Jan 
Date Detail:
Created Date:  1994-03-01     Completed Date:  1994-03-01     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  0370476     Medline TA:  Am J Obstet Gynecol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  236-45     Citation Subset:  AIM; IM    
Affiliation:
Department of Obstetrics and Gynecology, University of Texas Medical Branch, Galveston 77551.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Arginine / analogs & derivatives,  pharmacology
Biological Assay
Dose-Response Relationship, Drug
Endothelium, Vascular / metabolism,  secretion
Female
Histamine / pharmacology,  physiology
Humans
Nitric Oxide / metabolism,  physiology*,  secretion
Nitroarginine
Nitroglycerin / pharmacology
Potassium / pharmacology
Pregnancy / physiology*
Pregnancy Trimester, Second
Pregnancy Trimester, Third
Pyrilamine / pharmacology
Superoxide Dismutase / pharmacology
Umbilical Arteries / physiology*
Vasodilation / drug effects,  physiology*
Grant Support
ID/Acronym/Agency:
ES04312/ES/NIEHS NIH HHS
Chemical
Reg. No./Substance:
10102-43-9/Nitric Oxide; 2149-70-4/Nitroarginine; 51-45-6/Histamine; 55-63-0/Nitroglycerin; 74-79-3/Arginine; 7440-09-7/Potassium; 91-84-9/Pyrilamine; EC 1.15.1.1/Superoxide Dismutase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Rat embryo development on human sera is related to numbers of previous spontaneous abortions and nut...
Next Document:  The p53 tumor suppressor gene frequently is altered in gynecologic cancers.